Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?
about
A peptide probe for the detection of neurokinin-1 receptor by disaggregation enhanced fluorescence and magnetic resonance signals.Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengthsHydrodenticity to enhance relaxivity of gadolinium-DTPA within crosslinked hyaluronic acid nanoparticles.Preparation of highly efficient MRI contrast agents through complexation of cationic Gd(III)-containing metallosurfactant with biocompatible polyelectrolytes.MRI-visible polymer based on poly(methyl methacrylate) for imaging applicationsAsymmetrically functionalized β-cyclodextrin-based star copolymers for integrated gene delivery and magnetic resonance imaging contrast enhancement
P2860
Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Macromolecular Imaging Agents ...... se Lead to Clinical Potential?
@ast
Macromolecular Imaging Agents ...... se Lead to Clinical Potential?
@en
type
label
Macromolecular Imaging Agents ...... se Lead to Clinical Potential?
@ast
Macromolecular Imaging Agents ...... se Lead to Clinical Potential?
@en
prefLabel
Macromolecular Imaging Agents ...... se Lead to Clinical Potential?
@ast
Macromolecular Imaging Agents ...... se Lead to Clinical Potential?
@en
P2093
P2860
P356
P1433
P1476
Macromolecular Imaging Agents ...... se Lead to Clinical Potential?
@en
P2093
Jeffrey W Reineke
Joshua Bryson
Theresa M Reineke
P2860
P304
P356
10.1021/MA301568U
P577
2012-11-13T00:00:00Z